Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long-Acting PTH.

Sato, Tadatoshi et al.·JBMR plus·2021·Moderate Evidencein-vitro
RPEP-05742In VitroModerate Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Moderate Evidence
Sample
N=not applicable
Participants
Cell-based comparison of three PTH1R peptide ligands across multiple signaling assays

What This Study Found

Teriparatide, abaloparatide, and LA-PTH showed comparable PTH1R downstream signaling (cAMP, calcium, SIK, gene expression) in vitro, with abaloparatide uniquely showing faster receptor recycling after washout.

Key Numbers

3 ligands; no difference in cAMP, calcium, β-arrestin, SIK2, gene expression; abaloparatide faster receptor recycling; comparable at all tested concentrations

How They Did This

Lab study comparing three PTH1R ligands across multiple cell-based signaling assays: receptor internalization, beta-arrestin recruitment, intracellular calcium, cAMP, SIK2 phosphorylation, substrate dephosphorylation, and gene expression changes.

Why This Research Matters

Understanding why similar peptide drugs have different clinical effects is key to designing better bone therapies. If the difference is pharmacokinetic rather than signaling-based, it changes how we optimize these drugs.

What This Study Doesn't Tell Us

In vitro study only. Cell-based assays may not capture the full complexity of PTH1R signaling in bone cells in vivo. Only short-term signaling was measured. Pharmacokinetic differences were proposed but not tested.

Trust & Context

Original Title:
Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long-Acting PTH.
Published In:
JBMR plus, 5(5), e10441 (2021)
Database ID:
RPEP-05742

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Cite This Study

RPEP-05742·https://rethinkpeptides.com/research/RPEP-05742

APA

Sato, Tadatoshi; Verma, Shiv; Khatri, Ashok; Dean, Thomas; Goransson, Olga; Gardella, Thomas J; Wein, Marc N. (2021). Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long-Acting PTH.. JBMR plus, 5(5), e10441. https://doi.org/10.1002/jbm4.10441

MLA

Sato, Tadatoshi, et al. "Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long-Acting PTH.." JBMR plus, 2021. https://doi.org/10.1002/jbm4.10441

RethinkPeptides

RethinkPeptides Research Database. "Comparable Initial Engagement of Intracellular Signaling Pat..." RPEP-05742. Retrieved from https://rethinkpeptides.com/research/sato-2021-comparable-initial-engagement-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.